Best IPOs for Long Term Investment: The Smartest Framework Indian Retail Investors Can Use in 2026

best ipos for long term investment

Best IPOs for Long Term Investment are not the ones with the highest Grey Market Premium on Day 3 of subscription. They are IPOs of companies that were already generating revenue growth, expanding profit margins, and building competitive positions before the listing day — companies where the IPO is an event in the business’s history, not the business itself. This distinction is the only one that separates the compounders from the disappointments for investors who intend to hold shares for 3, 5, or 10 years rather than sell within 30 minutes of listing.

The evidence from India’s IPO market makes the argument plainly: Avenue Supermarts listed at ₹299 in 2017 and crossed ₹5,000 — a 15x+ return driven by consistent store-level profitability and a defensible low-price retail model. Paytm listed at ₹2,150 in 2021 and fell below ₹500 within two years — a 75%+ loss driven by unsustainable cash burn and a business model that required indefinite capital subsidy to generate revenue. Both received heavy retail participation. The difference was entirely in the business quality, not the subscription frenzy.

This article covers a complete framework for identifying the best IPOs for long term investment in India: the three categories that define long-term IPO outcomes, six specific metrics to check in the Red Herring Prospectus, which sectors historically produce durable compounders, and five actionable tips for applying this framework to upcoming IPOs.


Which IPO Is Best for Long Term Investment — The Question Most Investors Ask Wrong

Most retail investors frame the question as “which IPO should I apply for?” — and look for a name. The more productive question is: “what characteristics make any IPO worth holding long term?” The answer applies to every IPO that will ever open, not just the one currently trending on financial news platforms.

Three categories define long-term IPO outcomes in India’s market.

Category 1 — Profitable companies with clear competitive moats. Avenue Supermarts (2017, ₹299 issue price) was profitable with an expanding store network and an everyday-low-price model that competitors could not replicate without permanently sacrificing margins. IRCTC (2019, ₹320 issue price) held a statutory monopoly on Indian railway ticketing — the government would never allow a competitor or the business to fail. Both investment theses were visible from the Red Herring Prospectus before subscription opened, not from the subscription multiple that followed. The best IPOs for Long Term Investment almost always fit this template.

Category 2 — Growth-stage loss-makers with a credible and visible path to profitability. Some companies list before reaching profitability but with unit economics that improve predictably as scale increases. The risk is distinguishing genuine growth-stage losses (revenue expands as losses shrink per unit) from structural losses (the business model requires permanent subsidy). Category 2 requires significantly deeper analysis of the RHP’s segment-level financials and customer acquisition cost trends.

Category 3 — Richly valued companies with no earnings visibility. Paytm’s ₹2,150 issue price embedded profitability assumptions that did not materialise on any disclosed timeline. LIC’s ₹949 issue price in 2022 valued the insurer at a significant premium to embedded value without accounting for the structural constraints of a PSU in a competitive market. CarTrade Tech (₹1,618 issue price) showed revenue growth without a credible path to the margins needed to justify that valuation. Category 3 is where most retail long-term disappointments originate.

The practical filter: before applying to any IPO with a long-term holding intent, retail investors should identify which category the company belongs to from the RHP’s financials alone — independent of GMP, media coverage, or subscription figures.


How to Select IPOs for Long Term Investment — Six Metrics From the Red Herring Prospectus

The Red Herring Prospectus (RHP) filed with SEBI is the only legally binding source of information about any IPO. Six specific metrics within it determine whether an IPO deserves a place in a long-term portfolio.

Metric 1 — Revenue growth (three-year trend). The RHP mandates at least three years of audited financial statements. Revenue growing consistently at 15–20%+ annually, without a single customer exceeding 20–25% of total revenue, signals an expanding business with distributed demand. Stagnant or declining top-line revenue accompanying a large IPO issuance is a capital event for insiders with no growth story attached.

Metric 2 — Profit growth and net margin trend. Revenue growth accompanied by stable or expanding net margins confirms that growth is not purchased through discounts or disproportionate spending. When net margins compress as revenue grows, the company is buying market share — a model that depends on continued capital injection rather than operational strength. Target thresholds: above 10% net margin for manufacturing and services, above 15% for pharma and software.

Metric 3 — Operating cash flow versus net profit. Book profits and cash generation are separate measurements. A company reporting ₹100 crore PAT while generating ₹20 crore operating cash flow has an earnings quality problem — usually attributable to aggressive revenue recognition or rising receivables. Operating cash flow that matches or exceeds net profit is the earnings quality confirmation that most retail investors skip entirely.

Metric 4 — IPO valuation at upper band. Calculate the post-issue market capitalisation at the upper band and divide by the most recent full-year PAT to get the trailing P/E. Compare that figure to the P/E of three listed peers on NSE India. An IPO priced at 60x P/E when the sector median is 30x requires two years of perfect execution before a retail investor who applies at the IPO price receives market-average returns. That leaves no room for error — and businesses always produce errors.

Metric 5 — Management quality and promoter stake post-listing. The RHP’s management section discloses prior business history, legal proceedings, and SEBI enforcement actions. Promoters selling more than 30% of their total holding at IPO signal reduced long-term alignment — the people who know the business best are reducing their exposure. Promoters retaining 60%+ post-listing keep their personal wealth tied to the stock’s long-term trajectory.

Metric 6 — Industry position and competitive moat. Market leaders with pricing power — FMCG brand owners, pharma patent holders, regulated utilities — sustain margins through economic downturns better than commodity suppliers. The RHP’s industry overview (typically from a third-party research firm) provides market share data that, even if directionally approximate, confirms whether the company leads or follows in its category.


Best IPOs for Long Term Returns — What India’s History Shows

The table below contrasts the two approaches Indian retail investors use when evaluating IPOs, and maps each to its historical outcome pattern.

Evaluation FactorLong-Term Investment ApproachListing-Day Speculation Approach
Primary decision signal3-year revenue and profit growth in RHPGMP on Day 2 or Day 3 of subscription
IPO valuation checkP/E vs listed sector peers at upper bandNot checked — focus is on listing premium
Holding period intended3–10 years30 minutes to 30 days post-listing
Subscription level used asOne signal among many (institutional confidence)Primary entry signal — high sub = buy
Cash flow analysisOperating cash flow vs PAT — checkedNot relevant to short holding period
Management track recordRead in full from RHPNot relevant to short holding period
Sector and market positionIndustry overview section of RHP — analysedNot relevant
Historical outcome (India, 2015–2024)DMart (15x+), IRCTC (3x+), Varun Beverages (5x+)Paytm (−75%), LIC (flat 18+ months), CarTrade (−60%)
Main riskGetting the long-term thesis wrong as business changesGetting the sentiment wrong — GMP collapses on listing day
Best suited forInvestors with 3+ year horizon and research disciplineTraders with active capital management and exit discipline

The best IPOs for Long Term Investment from India’s decade-long record — DMart (2017), IRCTC (2019), Varun Beverages (2016), SBI Life Insurance (2017) — shared one observable characteristic at listing day: they were already profitable, already market leaders in durable demand categories, and listed at valuations that left room for earnings growth without requiring perfect execution. Their long-term returns reflected business performance, not listing-day sentiment.

Delhivery (₹487 issue price, 2022) and CarTrade Tech (₹1,618, 2021) carried revenue growth but listed into structural profitability questions — and underperformed for years. The variable separating the two groups was IPO fundamentals visible in the RHP before subscription opened, not anything discoverable only after listing.


Best IPOs to Buy and Hold in India — Sectors That Historically Compound

Certain sectors produce durable long-term IPO performers with higher consistency than others. This is not a guarantee — execution still matters — but the structural tailwinds make the investment thesis more forgiving.

FMCG and Consumer Staples. India’s consumption growth is a multi-decade structural story driven by a rising middle class and increasing discretionary spending. Consumer companies with strong brands, gross margins above 50%, and distribution networks built over decades are natural compounders. The risk: IPO valuations are often rich precisely because everyone understands the thesis.

Pharmaceuticals. India’s generic drug export advantage to regulated US and EU markets, combined with a rapidly expanding domestic healthcare spend, creates long-running revenue growth for companies with regulatory-approved facilities. Recent pharma IPOs — including the Symbiotec Pharmalab IPO reviewed on this site — illustrate how a pharma company with 15%+ revenue growth and a 12%+ net margin at listing offers a thesis that extends well beyond the subscription period. The risk: a single US FDA warning letter can remove a regulated-market revenue stream and halve the valuation.

Specialty Chemicals. India’s role in global supply chain diversification away from China produces IPO candidates with strong export contracts, multi-year customer relationships, and differentiated product portfolios. Companies with patented chemistries or exclusive supply agreements are particularly attractive for long-term holding.

Financial Services — Insurance and AMCs. India’s life insurance penetration runs at approximately 3% of GDP versus 8–10% in developed markets. Asset management penetration is similarly low relative to population. SBI Life Insurance and HDFC Life have compounded strongly since their IPOs for this structural reason — the market they serve is still in its early growth phase.

Sectors to research with extra scrutiny: edtech (high customer acquisition cost, weak retention), loss-making new-age consumer marketplaces (no pricing power against large incumbent platforms), highly leveraged real estate developers (project concentration risk), and commodity businesses like steel and cement (cyclical, not compounder profiles).


Best Upcoming IPOs for Long Term Investment — The Research Workflow

best ipos for long term investment alt

Identifying the best upcoming IPOs for long term investment requires a disciplined pre-application workflow, applied consistently regardless of sector or IPO size.

Read the financial statements before the company overview. Pages 200–350+ in a typical mainboard RHP carry three years of audited financials. These are the only numbers with legal liability attached. The company overview section that precedes it is authored by the company’s management and underwriters — useful context, not independent analysis.

Check the objects of the issue. The “Objects of the Issue” section states what the fresh issue proceeds fund. Debt repayment as the primary object means the company needed IPO capital to reduce existing leverage — investigate why that debt exists. Capex for capacity expansion and working capital for order-book growth are more favourable objects.

Identify who is selling in the OFS and at what cost of acquisition. A promoter selling 50 lakh shares via OFS who originally acquired them at ₹10 per share and is now selling at ₹988 captures a 98x return from the IPO capital event. The company and its public shareholders receive nothing from that transaction. High promoter OFS scale combined with low promoter acquisition cost is a structural misalignment worth factoring into the investment decision.

Apply the PEG check alongside the P/E check. A pharma company growing revenue at 25% annually justifies a higher P/E than one growing at 12% in the same sub-segment. Pure P/E comparison misses this growth differential. The PEG ratio — P/E divided by earnings growth rate — provides a more accurate valuation comparison across companies growing at different rates. Apply this using the RHP’s 3-year PAT growth figure combined with the NSE peer P/E data.

Treat GMP as a sentiment signal, not an investment signal. GMP forecasts 3 days of secondary market sentiment, not 3 years of business performance. An IPO with strong GMP and weak fundamentals delivers listing-day euphoria followed by a multi-year correction. An IPO with zero GMP and strong fundamentals delivers a flat or modest listing followed by years of compounding. For a framework on structuring the long-term equity portfolio that incorporates IPO allocations alongside mutual funds and direct stocks, the long term investment strategy guide covers position sizing and asset allocation in detail.


5 Tips for Selecting the Best IPOs for Long Term Investment

1. Read the RHP’s risk factors section, not just the financial highlights. The risk factors section (typically 50–80 pages in a mainboard RHP) discloses every material business risk the company’s lawyers identified — regulatory exposure, customer concentration, key personnel dependence, litigation. Retail investors who read only the financial summary in IPO review articles miss the specific scenarios that could impair the long-term thesis.

2. The best IPOs for Long Term Investment have already passed the unit economics test. Companies that raised venture or private equity capital and reached profitability before the public IPO proved their business model under competitive conditions. Companies using IPO proceeds to fund experiments that the private market declined to back are transferring risk to retail investors. Require evidence that unit economics work before the IPO, not projections that they will.

3. Cap any single IPO position at 3–5% of the equity portfolio. A US FDA warning letter, a promoter fraud allegation, or a single supply chain disruption can halve a pharma or manufacturing IPO regardless of how strong the long-term thesis appeared at listing. Long-term compounding requires portfolio survival through black-swan events. A 3–5% allocation cap allows the position to compound without creating existential risk if the thesis fails.

4. Set a 12-month no-review commitment before applying. The first 12 months of IPO ownership are the most dangerous period for decision quality. Listing-day losses trigger premature exits from positions with 5-year theses. Listing-day gains trigger overconfidence that inflates future position sizing. A deliberate 12-month holding commitment, broken only by a materially adverse business development disclosed in a quarterly result, removes short-term market noise from a long-term capital decision.

5. Use the NSE and BSE screeners to build a peer P/E table before every IPO application. BSE (https://www.bseindia.com) and NSE publish real-time P/E data for all listed stocks by sector. Before applying to any IPO, build a five-company peer comparison table using the sector filter. If the IPO’s trailing P/E at upper band exceeds the peer group median by more than 30% without a proportionally higher growth rate, the valuation premium requires justification from the RHP’s growth trajectory — not from GMP sentiment.


Frequently Asked Questions — Best IPOs for Long Term Investment

Q1. Which IPO is best for long term investment in India? No single IPO name applies universally — the best long-term IPO is always the one where business quality justifies the valuation at the time of application. Historically, Indian IPOs that produced the strongest long-term returns — Avenue Supermarts, IRCTC, Varun Beverages, SBI Life — shared three characteristics: consistent revenue growth before listing, net profitability at IPO, and market leadership in a category with durable demand. Retail investors who screen upcoming IPOs against these three criteria identify candidates worth deeper analysis from the RHP.

Q2. How long is the right holding period for an IPO position? The holding period should match the investment thesis, not a calendar. If the reason for applying was “this business will grow earnings at 15–20% annually for five years,” the holding period is five years or until that thesis changes — through competitive disruption, management failure, or regulatory reversal. Listing-day performance, up or down, should not trigger an exit from a position held on a verified long-term thesis. Annual review against the company’s results and annual report is the appropriate cadence.

Q3. Can retail investors genuinely build wealth through IPO investments? Yes — but only through business selection, not subscription selection. SEBI’s retail investor data consistently shows most retail applicants exit within three months of listing, capturing short-term gains or cutting short-term losses. The minority who identify quality businesses at reasonable valuations and hold for five or more years have historically outperformed the Nifty 50 from those positions. The compounding is real; the discipline required to access it is harder than the subscription process.

Q4. Does IPO valuation matter if the business is growing fast? Valuation matters as much as growth — it determines what growth rate is already priced in. Two businesses with identical 20% annual revenue growth produce dramatically different returns for investors who enter at 20x P/E versus 60x P/E at listing, even if both execute perfectly for five years. Higher starting valuations compress the investment return regardless of business quality. Requiring a valuation at or near sector median P/E — or a materially higher growth rate to justify a premium — protects the return outcome.

Q5. What are the best IPOs to buy and hold in India going forward? Rather than naming specific names, applying the five-factor filter identifies candidates: (1) three-year revenue growth above 15% with consistent profitability, (2) operating cash flow at or above net profit, (3) promoter retention above 60% post-listing, (4) trailing P/E at upper band at or below listed peer median, (5) sector with structural demand growth over a decade. Any upcoming IPO that clears all five criteria belongs on the best IPOs for Long Term Investment shortlist for further due diligence.


Disclaimer

This article is published for educational and informational purposes only. All historical IPO examples — DMart, IRCTC, Varun Beverages, SBI Life, Paytm, LIC, CarTrade, Delhivery — are cited for illustrative purposes based on publicly available post-listing performance data. Past performance of any listed company does not guarantee future returns. ipocontrol.in is not registered with SEBI as a research analyst or investment advisor. Nothing in this article constitutes investment advice, a buy or sell recommendation, or a solicitation to apply for any IPO. IPO investments carry significant market risk, including the risk of partial or full loss of invested capital. Retail investors should read the Red Herring Prospectus in full and consult a SEBI-registered financial advisor before making any investment decision.


The IPO Window Is Three Days — The Investment Window Is Three Decades

The best IPOs for Long Term Investment share one defining characteristic — the business was already worth owning before the IPO opened. Avenue Supermarts did not need the retail investor’s capital to prove its stores were profitable. IRCTC did not need the IPO to establish that its railway ticketing monopoly was durable. Varun Beverages did not need public capital to demonstrate that its Pepsi franchise distribution model generated consistent cash flows. These companies used the IPO to provide liquidity to early investors — not to validate a model that had not yet been proved.

For retail investors evaluating the best IPOs for Long Term Investment in 2026, the workflow is repeatable: read three years of RHP financials before reading the company narrative, calculate trailing P/E against listed sector peers at the upper band, confirm operating cash flow matches net profit, verify promoter retention above 60% post-listing, and allocate 3–5% of the equity portfolio at cut-off price. The subscription window closes in three days. Genuine compounding from a quality business runs for three decades. The evaluation should take proportionally longer than the application.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top